An immunomodulatory and Myotrophic Formulation with Simultaneous Neurotrophic Properties for The Treatment of ALS and Multiple Sclerosis

An Immunomodulatory Formulation consisting of Nf-Kappa B, TNF-A and IL-6 Suppressive protopanaxatriol Class glucopyranoside Analouges, A Neurotrophic Protobioside Analouge that Promotes Myelin Regeneration, A Myotrophic Bioceutical Extract with Partial SARM-Like Effects thus increasing Muscle Mass via Protein Synthesis Enhancement, via GDF-8 Suppression, increasing intramascular MGF and IGF-1 mRNA Expression and Enhancing Cholinergic Neuromascular Transmission Duration. By Inhibiting Pro-Inflammatory Cytokine Release and via increasing Selective Anabolism Formulation Serves as an Effective Adjunctive Treatment for ALS and Multiple Sclerosis. Inventors: Erdal Can Alkoclar Metehan Yesil